Escalating Immunotherapy of Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9913|42|3|121-127

ISSN： 0014-3022

Source： European Neurology, Vol.42, Iss.3, 1999-10, pp. : 121-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 186-187

Karger

Access to resources Recommend Favorite

Multiple Sclerosis after Allergen-Specific Immunotherapy and Influenza Vaccination

By  

European Neurology, Vol. 50, Iss. 4, 2003-11 ,pp. : 248-249

Karger

Access to resources Recommend Favorite

CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?

By  

Current Immunology Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 173-176

Bentham Science Publishers

Access to resources Recommend Favorite

On the Prevalence of Multiple Sclerosis in Serbia

By  

Neuroepidemiology, Vol. 37, Iss. 2, 2011-09 ,pp. : 107-108

Karger

Access to resources Recommend Favorite

Historical Descriptions of Multiple Sclerosis

By  

European Neurology, Vol. 54, Iss. 1, 2005-09 ,pp. : 49-53

Karger

Access to resources Recommend Favorite